[The outlook for developing recombinant vaccines based on mycobacteria].
The paper provides the data available in the literature on the present-day direction in exploitation of recombinant vaccines on the basis of Mycobacterium spp. Special attention is paid to the nature of shuttle vectors for Mycobacterium spp. and E. coli.
Lazarenko
V N
VN
Makhlaĭ
A A
AA
Khomenko
A G
AG
D001428:Bacterial Vaccines / Q000235:genetics / Q000302:isolation & purification*; D004269:DNA, Bacterial / Q000235:genetics; D004274:DNA, Recombinant / Q000235:genetics; D015195:Drug Design; D005821:Genetic Techniques; D005822:Genetic Vectors; D009161:Mycobacterium / Q000235:genetics / Q000276:immunology*; D010957:Plasmids; D014613:Vaccines, Attenuated / Q000235:genetics / Q000302:isolation & purification; D014614:Vaccines, Synthetic / Q000235:genetics / Q000302:isolation & purification*
D001428:Bacterial Vaccines; D004269:DNA, Bacterial; D004274:DNA, Recombinant; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic